{Reference Type}: Case Reports
{Title}: Mycobacterium colombiense Pneumonia in HIV-Infected Patients: Three Case Reports and a Literature Review.
{Author}: Guo Y;Li X;Xiao Q;Yang J;Tao R;Xu L;Zhu B;
{Journal}: Infect Drug Resist
{Volume}: 16
{Issue}: 0
{Year}: 2023
{Factor}: 4.177
{DOI}: 10.2147/IDR.S441083
{Abstract}: UNASSIGNED: Mycobacterium colombiense pneumonia in HIV-infected patients is relatively unusual but is associated with a high mortality rate, as well as high rates of misdiagnosis and delayed diagnosis. Clinical metagenome next-generation sequencing (mNGS) may have potential for its accurate and timely diagnosis.
UNASSIGNED: We retrospectively reviewed the medical records of three HIV-infected patients who presented with M. colombiense pneumonia in Zhejiang Province between January 2019 and December 2020. No specific clinical presentations or radiological manifestations were found in any of the patients. The detection of M. colombiense is 28-55 days earlier using mNGS on bronchoalveolar lavage fluid (BALF) compared to traditional culture methods. A combined treatment of rifabutin, clarithromycin, or azithromycin, and ethambutol did not provide timely relief of symptoms in these three patients. In the early stage of treatment, moxifloxacin and linezolid were used for several weeks. The average course of treatment for all three patients was close to 17 months.
UNASSIGNED: We recommend early BALF mNGS for fast and accurate diagnosis of M. colombiense pneumonia in HIV-infected patients with low CD4 counts and long duration of symptoms. Further, moxifloxacin and linezolid may be beneficial in the early stage of treatment.